Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02919475 · ClinicalTrials.gov registry record · Phase 2

Study to Evaluate Efficacy, Safety and Tolerability of JTE-051 in Subjects With Active Rheumatoid Arthritis

A Phase 2 study of Rheumatoid Arthritis, sponsored by Akros Pharma.

Completed
Registry status
Phase 2
Development phase
260
Enrollment target
20
Study locations

NCT02919475 is a Phase 2 study of Rheumatoid Arthritis that has completed, run by Akros Pharma. The registered enrollment target is 260 participants, below the 4,689-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (94% lower). The trial reports 20 study locations across 14 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02919475, a Phase 2 study of Rheumatoid Arthritis, has completed, sponsored by Akros Pharma.

COMPLETED
Registry status
Phase 2
Development phase
260 participants
Enrollment target
20
Study locations

Study Summary

This study will evaluate the efficacy, safety, tolerability and pharmacokinetics (PK) of JTE-051 administered for 12 weeks in subjects with active rheumatoid arthritis who are receiving background non-biologic disease-modifying anti-rheumatic drug therapy.

Conditions Studied

Rheumatoid Arthritis

Interventions

  • DRUG Placebo
  • DRUG JTE-051

Study Locations (20)

Other

  • - Córdoba
  • - San Juan
  • - Lom
  • - Plovdiv
  • - Sevlievo
  • - Sofia

Buenos Aires

  • - La Plata
  • - San Fernando

Arizona

  • - Tucson

California

  • - Upland

Florida

  • - Clearwater

Tennessee

  • - Hendersonville

Córdoba Province

  • - Barrio Norte

Tucumán Province

  • - San Miguel de Tucumán

Trial Details

FieldValue
Enrollment Target 260 participants
Start Date 2016-09-14
Est. Completion 2018-06-25
Phase Phase 2

Sponsor

Akros Pharma

18 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02919475

The ClinicalTrials.gov registry entry for NCT02919475 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,689-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (94% lower). The listed sponsor is Akros Pharma, which has 18 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT02919475 reports 20 study locations spanning 14 distinct geographic areas - top geographies include Other, Buenos Aires, Arizona.

Frequently Asked Questions

What is clinical trial NCT02919475 about?

NCT02919475 is a clinical study titled "Study to Evaluate Efficacy, Safety and Tolerability of JTE-051 in Subjects With Active Rheumatoid Arthritis". This study will evaluate the efficacy, safety, tolerability and pharmacokinetics (PK) of JTE-051 administered for 12 weeks in subjects with active rheumatoid arthritis who are receiving background non-biologic disease-modifying anti-rheumatic drug therapy.

What is the current status of trial NCT02919475?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 260 participants. The study started on 2016-09-14. Estimated completion is 2018-06-25.

What conditions does trial NCT02919475 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis.

What interventions are being tested in trial NCT02919475?

The interventions under investigation include: Placebo (DRUG), JTE-051 (DRUG).

Who is sponsoring clinical trial NCT02919475?

This trial is sponsored by Akros Pharma, which has 18 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02919475 being conducted?

This trial has 20 study locations across Arizona, California, Florida, Tennessee, Buenos Aires. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Rheumatoid Arthritis

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.